Global Health Limited (MEDANTA) — Board Meeting Announcement

· NSE 🟡 Notable Neutral
📢 Key Event
Board approved FY2026 audited results and final dividend recommendation
🔄 What Changed
Finalized audited financials with ₹1,275.58 million comprehensive income and ₹18.46 EPS; proposed ₹0.50 dividend
🔮 What's Next
No forward guidance provided
💡 Investor Takeaway
The approved dividend and strategic appointments signal confidence in financial health and growth trajectory

Global Health Limited's board approved audited FY2026 results showing ₹1,275.58 million total comprehensive income and ₹18.46 EPS, recommended a final dividend of [amount context mismatch] per share, appointed two new executives, and accepted one resignation. The audit confirmed no material uncertainty, with exceptional items including ₹365.98 million labor code charges and ₹498.96 million stamp duty reversals. Approved lease arrangements for new hospitals and employee stock options underscore strategic expansion.

📄 View Original Announcement (PDF)

About Global Health Limited (MEDANTA)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹33,404.85 Cr P/E: 65.8

View full MEDANTA stock details →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.